LONA

LeonaBio, Inc.

Biological Products, (No Diagnostic Substances)Nasdaq<br>Emerging growth company

Total Trades

10

Buys

0

Sells

5

Largest Trade

N/A

Insiders

5

Institutional Funds

29

Inst. Value

$1M+

Activist Filings

5

Insider Trades

InsiderTitleTypeValueSharesPriceDate
Litton Mark JamesPRESIDENT and CEOEXERCISEN/A22KMar 6, 2026
Litton Mark JamesPRESIDENT and CEOSELL$15K–$50K5K$5.37Mar 6, 2026
Renninger RobertCHIEF FINANCIAL OF…EXERCISEN/A4KMar 6, 2026
Renninger RobertCHIEF FINANCIAL OF…SELL$1K–$15K906$5.37Mar 6, 2026
Worthington MarkGENERAL COUNSEL an…EXERCISEN/A6KMar 6, 2026
Worthington MarkGENERAL COUNSEL an…SELL$1K–$15K1K$5.37Mar 6, 2026
CHURCH KEVINCHIEF SCIENTIFIC O…EXERCISEN/A6KMar 6, 2026
CHURCH KEVINCHIEF SCIENTIFIC O…SELL$1K–$15K1K$5.37Mar 6, 2026
San Martin JavierCHIEF MEDICAL OFFI…EXERCISEN/A7KMar 5, 2026
San Martin JavierCHIEF MEDICAL OFFI…SELL$1K–$15K2K$5.37Mar 5, 2026
🔓Seeing ranges? Sign in for exact trade values — free forever

Institutional Ownership

13F filings as of Dec 31, 2025 · 29 funds holding

Activist & 5%+ Owners

SC 13D/13G filings — investors holding 5%+ of outstanding shares

Baselake Partners, LP

SC 13G/A · Feb 6, 2026

1.9%

76K shares

Perceptive Advisors LLC

SC 13D/A · Jan 16, 2026

20.0%

1.9M shares

Perceptive Advisors LLC

SC 13D/A · Dec 23, 2025

20.0%

1.9M shares

Perceptive Advisors LLC

SC 13D/A · Dec 22, 2025

13.7%

540K shares

Baselake Partners, LP

SC 13G · Nov 14, 2025

5.0%

197K shares

View on Google Finance →